SCRI- Colorado Blood Cancer Institute — Denver, Colorado

SCRI- Colorado Blood Cancer Institute is a clinical research site located in Denver, Colorado, United States 80218.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

SCRI- Colorado Blood Cancer Institute has participated in 1 clinical trials.

Therapeutic areas: Acute Myeloid Leukemia.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for SCRI- Colorado Blood Cancer Institute?

SCRI- Colorado Blood Cancer Institute has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has SCRI- Colorado Blood Cancer Institute conducted?

SCRI- Colorado Blood Cancer Institute has 1 clinical trials on record. Their work covers Acute Myeloid Leukemia.

Is SCRI- Colorado Blood Cancer Institute accredited by Crixeo Health?

SCRI- Colorado Blood Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about SCRI- Colorado Blood Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.